Boston Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Boston Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6.24M	Buy	117,336 +92,736	+377%	+$4.76M	0.33%	85
2019 Q2	$1.26M	Buy	+24,600	New	+$1.15M	0.07%	306
2019 Q1	–	Sell	-53,884	Closed	-$2.12M	–	670
2018 Q4	$2.12M	Buy	+53,884	New	+$2.5M	0.12%	199
2017 Q4	–	Sell	-23,120	Closed	-$1.21M	–	679
2017 Q3	$1.21M	Buy	23,120 +410	+2%	+$22.9K	0.03%	337
2017 Q2	$1.33M	Sell	22,710 -149,790	-87%	-$7.78M	0.03%	343
2017 Q1	$7.91M	Sell	172,500 -60,329	-26%	-$3M	0.19%	156
2016 Q4	$12.2M	Buy	232,829 +23,514	+11%	+$1.14M	0.29%	105
2016 Q3	$9.33M	Buy	209,315 +72,086	+53%	+$3.13M	0.23%	138
2016 Q2	$5.23M	Sell	137,229 -31,665	-19%	-$1.39M	0.13%	196
2016 Q1	$6.96M	Sell	168,894 -51,610	-23%	-$2.13M	0.17%	149
2015 Q4	$10.7M	Buy	220,504 +77,657	+54%	+$3.45M	0.25%	120
2015 Q3	$5.71M	Buy	142,847 +125,327	+715%	+$5.47M	0.21%	145
2015 Q2	$703K	Buy	+17,520	New	+$604K	0.03%	363

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Advisors's SYNH Position: Q3 2019 in Review

Boston Advisors increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 377% in Q3 2019, buying an estimated $4.76M and bringing the position to 117,336 shares worth $6.24M. The position accounts for 0.33% of the portfolio, ranked #85.

Boston Advisors first reported a position in SYNH in Q2 2015 and has held it in 13 quarters since. The position peaked at $12.2M in Q4 2016. 259 funds tracked by Wall St. Rank hold SYNH as of Q3 2019.

Boston Advisors held 117,336 shares of Syneos Health, Inc. Class A Common Stock worth $6.24M as of Q3 2019.
Boston Advisors bought 92,736 Syneos Health, Inc. Class A Common Stock shares in Q3 2019, an estimated $4.76M.
Syneos Health, Inc. Class A Common Stock made up 0.33% of Boston Advisors's portfolio in Q3 2019, its #85 holding.
Boston Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and has held it in 13 quarters since.
Boston Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $12.2M in Q4 2016.
259 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.